Kmart to pay $32 million to settle drug overbilling allegations

WASHINGTON (Reuters) – Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Friday.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *